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Available online 16 December 2006Magnetic resonance imaging (MRI) is being used to probe the central
nervous system (CNS) of patients with multiple sclerosis (MS), a
chronic demyelinating disease. Conventional T2-weighted MRI (cMRI)
largely fails to predict the degree of patients' disability. This shor-
tcoming may be due to poor specificity of cMRI for clinically relevant
pathology. Diffusion tensor imaging (DTI) has shown promise to be
more specific for MS pathology. In this study we investigated the
association between histological indices of myelin content, axonal count
and gliosis, and two measures of DTI (mean diffusivity [MD] and
fractional anisotropy [FA]), in unfixed post mortem MS brain using a
1.5-T MR system. Both MD and FA were significantly lower in post
mortem MS brain compared to published data acquired in vivo.
However, the differences of MD and FA described in vivo between
white matter lesions (WMLs) and normal-appearing white matter
(NAWM) were retained in this study of post mortem brain: average
MD in WMLs was 0.35×10−3 mm2/s (SD, 0.09) versus 0.22 (0.04) in
NAWM; FA was 0.22 (0.06) in WMLs versus 0.38 (0.13) in NAWM.
Correlations were detected between myelin content (Trmyelin) and (i)
FA (r=−0.79, p<0.001), (ii) MD (r=0.68, p<0.001), and (iii) axonal
count (r=−0.81, p<0.001). Multiple regression suggested that these
correlations largely explain the apparent association of axonal count
with (i) FA (r=0.70, p<0.001) and (ii) MD (r=−0.66, p<0.001). In
conclusion, this study suggests that FA and MD are affected by myelin
content and – to a lesser degree – axonal count in post mortem MS
brain.
© 2006 Elsevier Inc.
Introduction
Histopathologically, central nervous system (CNS) tissue of
individuals with multiple sclerosis (MS) is characterized by
demyelination, axonal damage, gliosis, inflammation and often
some degree of remyelination. Whereas microscopically these
features can be readily appreciated, it has been proven difficult to
distinguish them in vivo using neuroimaging methods. T2 weighted
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Open access under CC BY license.(T2w) and gadolinium (Gd)-enhanced T1-weighted (T1w; both
techniques often summarized as “conventional”) magnetic reso-
nance imaging (MRI) displays MS white matter (WM) lesions
(WMLs) with high sensitivity and is helpful in diagnosis
(McDonald et al., 2001; Polman et al., 2005). Aside from a
relationship between Gd enhancement and inflammation (Hawkins
et al., 1990; Katz et al., 1993), however, such conventional MRI
(cMRI) techniques do not distinguish other histopathological
substrates of MS (Moore, 2003). The inability of cMRI to reflect
MS pathology in more detail may be one of the major reasons why
the correlation between cMRI measures and disability is only
modest (Kappos et al., 1999; Brex et al., 2002). Complementing
cMRI, quantitative MR measures have been developed that are
potentially more pathologically specific. These include diffusion-
weighted MRI (DWI), volumetric measurements, magnetization
transfer (MT) imaging, quantitative T1- and T2-relaxation time
(RT) measurements, and MR spectroscopic metabolite concentra-
tions (Tofts, 2003).
Increasing pathological specificity is worthwhile as it may help
to (i) further elucidate the pathogenesis of MS and (ii) monitor
treatments aimed at modifying specific processes. The investiga-
tion of post mortem tissue allows the direct assessment of the
relationship between MR measures and underlying pathology.
Such experiments have so far provided insights into the
pathological correlates of several MR indices including T1 hypo-
intensity (van Walderveen et al., 1998; van Waesberghe et al.,
1999; Barkhof et al., 2003), T1- (Schmierer et al., 2004a) and T2-
RT (Moore et al., 2000) and MT ratio (van Waesberghe et al.,
1999; Barkhof et al., 2003; Schmierer et al., 2004a).
DWI relies on the detection of changes in the random
translational motion of water molecules in tissue. For a
comprehensive description of the motion of water molecules, the
diffusion tensor can be estimated, provided diffusion tensor MRI
(DTI) is employed (Basser et al., 1994; Le Bihan et al., 2001;
Bammer et al., 2005). DTI requires the measurement of the MR
signal with diffusion sensitization along at least six non-colinear
non-coplanar directions and allows determination of three mutually
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sion) and the corresponding eigenvalues (giving its magnitude).
Various mathematical combinations of these values provide
rotationally invariant diffusion indices (i.e., measurements that
characterize a specific voxel independently of positioning in the
scanner) including mean diffusivity (MD) and fractional anisotropy
(FA). The latter describes the fact that in CNS WM, water
molecules are more likely to diffuse parallel to, rather than across,
fiber tracts. The FA value increases with this anisotropy and
provides a spatial depiction of anisotropic areas, whereas MD is an
index of the magnitude of water diffusion regardless of its direction
(Wheeler-Kingshott et al., 2003a).
DWI is sensitive to pathological processes that alter tissue
integrity, as these may result in changes to (i) the number and
permeability of biological barriers that normally restrict the motion
of water molecules, (ii) the relative sizes of intra-cellular, extra-
cellular or other compartments, or (iii) other tissue properties
affecting tissue anisotropy and diffusivity.
Using experimental allergic encephalitis (EAE), an animal
model of MS, an increase in diffusivity in MR detectable lesions
has been shown to be associated with a number of tissue alterations
including fibrosis of vessel walls, interstitial edema, vacuolization,
vesicular degeneration, myelin damage (Verhoye et al., 1996),
inflammatory infiltrates (Richards et al., 1995) and blood–brain
barrier leakage (Broom et al., 2005). However, reduced diffusivity
has also been observed in EAE, particularly in the lesion center
with abundant astrocytosis and densely packed macrophages
(Broom et al., 2005).
DWI has been widely applied to probe MS in vivo (Horsfield
and Jones, 2002; Filippi et al., 2003; Symms et al., 2004; Rovaris
et al., 2005; Bammer et al., 2005; Ge et al., 2005). Recently, it has
been suggested that DTI metrics provide a rather specific measure
of axonal loss (Hesseltine et al., 2006). However, investigation of
the pathological correlates of DWI in MS has been scarce
(Mottershead et al., 2003; Wheeler-Kingshott et al., 2003b;
Schmierer et al., 2004b; Fox et al., 2005). In this study we aimed
to systematically explore the association between quantitative
histological measures of myelin content, axonal count and gliosis
and two important indices of DTI (MD and FA) in post mortem
brain samples of 16 patients with MS.
Material and methods
Patients/samples
This study was approved by the Joint Ethics Committees of The
National Hospital for Neurology and Neurosurgery and the
Institute of Neurology, UCL. Post mortem brain slices of 16
patients with MS (15 women and 1 man) were provided by the UK
Multiple Sclerosis Tissue Bank (MSTB) based at Charing Cross
Hospital, Imperial College School of Medicine, London, UK. The
mean age of the patients was 59 years (SD: 13 years; range: 34–
82); their mean disease duration was 25 years (9; 6–43). The
course of MS (Lublin and Reingold, 1996) and the disability of the
patients were assessed retrospectively from the case records
collected at the MSTB. Disability was estimated using the
expanded disability status score (EDSS) scale (Kurtzke, 1983).
The brain weight and the pH of the cerebro-spinal fluid (CSF) of
each patient were provided by the MSTB.
Brains were retrieved by the MSTB a mean of 16 h (SD: 6 h;
range: 7–28 h) after death. One coronal brain slice (thickness:1 cm) of one hemisphere in each case was used for this study. The
mean time between tissue retrieval and dissection of the brain
slices was 4 h (SD: 2; median: 4; range: 1–8); the mean time
between death and MR scanning was 46 h (SD: 24; median: 39;
range: 10–107). The brain slices were stored in sealed plastic bags
at 2–8 °C until 3 h before scanning when they were taken out of the
refrigerator and plastic bags, wrapped in PVC foil to minimize
dehydration and left to reach scanner room temperature. To control
for the effects of temperature on the results, the temperature of the
samples was assessed immediately after scanning using a K-type
hypodermic thermocouple temperature probe connected to a HI
93551 thermometer (Hanna Instruments Ltd., Leighton Buzzard,
UK). After measuring the temperature specimens were immersed
in 10% buffered formalin solution.
MRI
Scanning was performed on a GE Signa Horizon Echospeed
1.5-T MR system (General Electric, Milwaukee, WI, USA). All
MR sequences were acquired as a single slice (thickness: 5 mm),
which was centered parallel to the coronal surface of the specimen.
The following sequences were performed:
(i) 2D spin echo (SE) T1w; repetition time [TR] 540 ms; echo
time [TE] 18 ms; and dual SE proton density (PD), and T2w
(TR 2000; TE 30 and 120 ms; flip angle 90°, matrix size
256×256). All these sequences were acquired twice, once
with a field of view [FOV] of 300×300 mm2 (to allow
visualization of fiducial markers of the custom-built sample
support, see further below), and again with a FOV of
240 mm×180 mm giving better resolution of anatomical
structures and lesions.
(ii) multi-shot diffusion-weighted spin echo EPI (TR/TE:
3000 ms/86 ms). The gradient b factor was 1940 s/mm2,
number of shots=8, number of excitations=4 (acquired
separately), FOV=12×12 cm2, matrix 48×48 (reconstructed
as 64×64) resulting in a pixel size of 2.5×2.5 mm2
(reconstructed 1.9×1.9 mm2). For each shot and average,
six diffusion-weighted images along six non-colinear direc-
tions, and one non-diffusion-weighted (b=0) image (i.e., with
b=0) were acquired. The directions of the diffusion
weighting were selected to apply maximum gradient strength
along two axes at a time and to obtain a high b factor without
increasing TE or loosing signal-to-noise. The scheme used
was (0 0 0, 1 1 0, 1 0 1, 0 1 1, −1 1 0, −1 0 1, 0 −1 1). Data
were processed to determine the diffusion tensor on a pixel-
by-pixel basis on each slice. Magnitude images of each slice
were reconstructed and averaged off-line, prior to being
processed to determine the diffusion tensor on a pixel-by-
pixel basis. MD and FA were calculated from the principal
diffusivities of the diffusion tensor (Wheeler-Kingshott et al.,
2003b). Note that high b values (reducing signal-to-noise)
were necessary because of the different range of the apparent
diffusion coefficient in post mortem brain.
All scans and maps were displayed on a Sun workstation (Sun
Microsystems, Mountain View, CA, USA) using DispImage
(Plummer, 1992). Regions of interest (ROIs) were defined and
labeled on the T2w scans, as follows: (i) areas of hyper-intense
signal suspected to be MS WMLs and (ii) two to three regions of
normal-appearing white matter (NAWM). ROIs on T2w scans
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to the difference in geometrical distortions, however, the position
of the ROIs on b=0 scans had to be determined visually with
reference to the corresponding T2w images. The ROIs on b=0
images were then marked and co-registered with the MD and FA
maps.
In order to optimize correspondence between ROIs defined on
MRI with their pathological substrate in the specimens a
stereotactic procedure (StP) was employed (Schmierer et al.,
2003). T1w, T2w, and PD images acquired with a FOV of
300×300 mm2 were used to determine the co-ordinates of (i) the
ROIs (with reference to the images acquired with a FOV of
240 mm×180 mm) and (ii) the fiducial points of the localizer of
the stereotactic system. The co-ordinates obtained at the scanner
were then processed using the StereoCalc™ program (Radionics,Fig. 1. Correlation of MRI and histopathology in post mortem multiple sclerosis br
seven exemplary regions of interest (marked in orange) were identified as either norm
WMLs are matched to respective histopathological sections, which were stained for
acid protein (GFAP) and Bielschowsky silver impregnation. Sections A–F illustra
indicating chronic inflammatory activity (chronic active WML), and an axonal
demyelinated lesion with very little inflammatory activity (chronic inactive WML
WML again with very little inflammatory activity (remyelinated WML) and an ax
Bielschowsky stained sections were divided into two halves (WML on the left and N
NAWM (green asterisks). MD=mean diffusivity×10−3 [mm2/s]; FA=fractional aBurlington, MA, USA) mounted on a laptop computer to give the
co-ordinates that allowed – in the dissection theatre – the pointer of
a Cosman–Roberts–Wells arc system (Radionics, Burlington, MA,
USA) to be guided towards the target points (i.e., the ROIs) in the
specimen. Every target point was then marked with a small dot of
tissue dye on the surface of the specimen. In nine/16 specimens the
entire MR and StP protocol was performed in one session before
fixation of the tissue. In seven/16 cases StP had to be performed
following a separate MR session after the tissue had been fixed as
previously described (Schmierer et al., 2003).
Pathological and morphometric procedures
Tissue blocks of approximately 1.5 cm×1.5 cm×1 cm in
volume and centered on each ROI were dissected. The blocks wereain (same case as in Fig. 2). On the T2-weighted scan of a coronal brain slice
al-appearing white matter (NAWM) or white matter lesions (WMLs). Three
hematoxylin and eosin (H&E), Luxol fast blue (LFB), CD68, glial fibrillary
te a demyelinated WML with moderate infiltration by CD68-positive cells
loss of 74% (compared to NAWM). Sections G–L show a hypo-cellular
). Axonal loss in this WML was 93%. Sections M–R show a remyelinated
onal loss of only 42%. Due to their high magnification (×1250) images of
AWM on the right). All other sections cover WMLs (red asterisks) as well as
nisotropy.
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blocks of equal thickness with the cut surface corresponding to the
center of the MR imaging plane. All dissected blocks were marked
with notches at known positions, usually on the ventral and lateral
cut surfaces, in order to assure the orientation in space after further
processing. Blocks were processed for embedding in paraffin.
Sections were stained with hematoxylin and eosin (H and E),
Luxol fast blue (LFB), and Bielschowsky’s silver impregnation.
Immunocytochemistry included antibodies to glial fibrillary acidic
protein (GFAP, 1/1500) and CD68 (1/100; both from Dako,
Glostrup, Denmark) Fig. 1.
Histologically, MS WMLs were defined in comparison to
surrounding NAWM as clearly distinct, sharply demarcated areas
of (i) essentially lost staining for LFB (demyelinated WMLs) or (ii)
uniformly thin myelin sheathing (in relationship to axon diameter),
which occurs either throughout the WML (fully remyelinated
“shadow” plaque) or at the edge of an otherwise demyelinated
WML (partially remyelinated plaque) (Prineas et al., 2002;
Barkhof et al., 2003; Brück et al., 2003). The minimum area of
remyelination required for a WML to be considered partially
remyelinated was 10% of the whole WML (Schmierer et al.,
2004a). Lesion stage was categorized as either early active (EA:
inflammation throughout the WML), chronic active (CA: hypo-
cellular center, inflammation only at the rim of the WML), or
chronic inactive (CI: no inflammation) (Fig. 1) (Trapp et al., 1998;
van der Valk and de Groot, 2000).
Axon counts were estimated on Bielschowsky-stained slides,
by a stereological method using a 21 bar (bar length: 13 μm)
quadrate grid graticule (size: 160×160 μm2) and a final
magnification of ×1250. Random points were superimposed over
WMLs and surrounding NAWM. On each slide the total number of
bars intersecting axons was counted in 12–16 areas of both the
WML and surrounding NAWM (Brück et al., 1997). The counts
were then averaged for each WML and respective NAWM ROI.
Myelin content was quantified in WML and NAWM by
assessing transmittance (Tr), defined as the transmitted light divided
by the incident light, on LFB-stained sections using a Leica
Q500MC digital image analyzer with a 256 grey scale resolution
(Leica Cambridge Ltd., UK), which was mounted on a Zeiss
photomicroscope 3 (Carl Zeiss, Jena, Germany). The program was
set in RGB mode, the white level was kept constant at 75% of the
maximum, and a final magnification of ×125was used.Within every
ROI (i.e., a WML or an equally sized region of NAWM adjacent to a
WML) the light intensity was assessed in three to five random areas
using a field size of 400×385 μm. The values obtained from each
area were averaged, and then divided by the light intensity
transmitted through the object slide (away from the tissue section)
to result in the Trmyelin values for WMLs and NAWM (Mize et al.,
1988; Gentleman et al., 1999; Schmierer et al., 2004a, b). A high
value of Trmyelin reflects low myelin content.Table 1
Overview of patients and lesion characteristics in post mortem brain slices of 16 p
Course n patients n white matter lesions
T2w T1w [percent of T2w] dWML
SP 10 24 12 [50] 16
PP 2 4 3 [75] 3
Unclear 4 10 7 [70] 9
SP=secondary progressive MS; PP=primary progressive MS; T2w=T2 weighted;
WMLs; EA=early active; CA=chronic active; CI=chronic inactive.Gliosis in WMLs and NAWM was classified on GFAP-stained
slides (i) by visual inspection as mild, moderate, or severe, and (ii)
quantitatively in WMLs and surrounding NAWM by light
transmittance in the same manner as for myelin content and
expressed as Trgliosis. A low value of Trgliosis reflects more severe
gliosis than a high Trgliosis.
The thickness of LFB- and GFAP-stained sections was assessed
using a stereological microscope and a final magnification of
×787.5, in order to control for possible effect of section thickness
on the measurements of Tr. On each slide, three to five
measurements were performed and averaged.
Statistical methods
Of the majority of MS cases used for this study more than one
tissue block was included in the analysis. Tissue blocks could
therefore not be analyzed as independent observations, i.e., without
taking into account within-patient dependency. We addressed this
“data hierarchy” by analyzing correlation either (a) between
patients, (b) within patients or (c) a combination of (a) and (b)
taking into account lack of independence.
Two methods were used to compare means: (i) to compare
means of variables in WMLs versus NAWM there was insufficient
within-patient variability. Hence, between-patient comparisons are
being reported in that paired t-tests were carried out on patient
means averaged across their respective tissue sample. (ii) To
compare means between demyelinated and remyelinated WMLs
(dWMLs and rWMLs, respectively) it was possible to use a
combination of between- and within-subject information. The
underestimated standard error and p values that would have
resulted using a simple t-test were inflated by using linear
regression according to the Huber–White method (Huber, 1967)
for inflating standard error, which resulted in correctly estimated p
values. The same approach was not possible to test for correlation
between MRI and pathology indices, as there was insufficient
between-patient variability to sustain consistent use of between-
patient information. Therefore, within-patient correlation was
obtained using Pearson correlation coefficients estimated from
fixed patient intercept regression (Baltagi, 1995), which ignores
between-patient differences and fits an estimated average regres-
sion slope to each patient's sample (the within-patient correlation
measures the strength of the correlation in tissue samples belonging
to the same patient).
Potential confounding by slide thickness or batch was
investigated by adding these terms to regression models where
appropriate (for slide batch, potential confounding is not applicable
to within-subject results, all of which were in the same batch).
Variation with batch was assessed using a random intercept model
to allow for within- and between-patient variability, with restricted
maximum likelihood estimation. Where there was doubt concern-atients with multiple sclerosis (38 white matter lesions, WMLs)
s rWMLs Partially rWMLs EA CA CI
3 5 0 5 19
0 1 2 0 2
0 1 0 4 6
T1w=T1 weighted; dWMLs=demyelinated WMLs; rWMLs=remyelinated
Fig. 2. T2-weighted (T2w) MRI, b=0, mean diffusivity (MD) and fractional anisotropy (FA) maps of post mortem multiple sclerosis brain. On T2w MRI of a
coronal brain slice, seven exemplary regions of interest (ROI; marked in orange) were identified as either normal-appearing white matter (NAWM) or white
matter lesions (WMLs). ROIs were visually matched with respective ROI on b=0 images, and then co-registered to the MD and FAmaps. One of the five WMLs
seen on T2w MRI (asterisk) could not be detected on diffusion maps.
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those from a non-parametric bias-corrected bootstrap with 1000
replicates (Carpenter and Bithall, 2000), and validity was
confirmed. Analyses were carried out using Stata 9.0 (Stata
Corporation, College Station, TX, USA).
Results
The clinical course had been secondary progressive in ten
subjects and primary progressive in two. In four subjects, the
clinical course could not be determined (Table 1). The estimated
mean EDSS was 8 (SD: 1; median: 8.5; range: 6.5–9). The mean
brain weight was 1131 g (SD: 113 g, range: 1000–1310 g). The pH
of the CSF was 6.9 (SD: 0.4, range: 6.5–7.5). The mean
temperature of the tissue during MRI was 22.3 °C (SD: 2.6 °C,
range: 17.5–25.1 °C).
Lesion findings
Seventy-five regions of high signal (RHS) thought to be MS
WMLs were detected on T2w MRI. Twenty-five/75 RHS had to be
discarded from further analysis due to (i) poor in-plane co-
registration between MRI and specimen (6), (ii) poor identification
of different tissue components on histology (5), (iii) misidentifica-
tion of a vascular lesion (1) or NAWM (10) as WMLs, and (iv)
other technical problems (3).
Of the remaining 50 WMLs, a further 12 had to be discarded
because no clear correspondence could be determined between the
T2w MRI and b=0 map (Fig. 2). Hence, 38 histologically
confirmed WML, visible on T2w MRI as well as b=0 images
were studied. Between one and six WMLs in each brain slice
(mean 2.4 WMLs; SD: 1.4 WMLs) could be used for the analysis.
Quantitative MR values were also obtained in two to three regions
of NAWM in each slice and then averaged.
Twenty-eight/38 WMLs (73.7%) were demyelinated, three
were fully remyelinated (7.9%) and seven partially remyelinated
(18.4%) (Table 1). Two/38 (2.6%) WMLs were classified as earlyactive, nine (23.7%) as CA, and 27 (71.1%) as CI WMLs. All
(fully or partially) rWMLs were CI WMLs.
Twenty-two/38 WMLs (57.9%) were hypo-intense and 16/38
(42.1%) iso-intense on T1w MRI. Fully rWMLs (shadow plaques)
represented two/22 (9.1%) T1 hypo-intense WMLs and 1/16
(6.25%) T1 iso-intense WMLs. Partially remyelinated WMLs
contributed three/22 (13.6%) T1 hypo-intense WMLs and four/16
(25%) T1 iso-intense WMLs.
Fibrillary gliosis was classified in 35/38 WMLs and observed
as being moderate in five/35 (14.3%), and severe in 30/35 (85.7%)
WMLs.
Comparison of MS lesions and NAWM
MD, FA, myelin content (Trmyelin), axonal count and gliosis
(Trgliosis) all differed significantly between WMLs and NAWM.
Results were similar when the analysis was restricted to (partially
or fully) rWMLs versus NAWM: rWMLs displayed significantly
higher MD, more pronounced gliosis and lower FA, myelin content
and axonal count (Table 2).
Correlation of MR diffusion and pathology
Myelin content (Trmyelin) correlated with FA (r=−0.79,
p<0.001) and MD (r=0.68, p<0.001). A similarly strong
correlation was detected between axonal count and both FA
(r=0.70, p<0.001) and MD (r=−0.66, p<0.001). A weaker
correlation emerged between both MD and gliosis (r=−0.55,
p=0.002) and FA and gliosis(r=0.50, p=0.004) (Table 3, Fig. 3).
Correlation between neuropathological features
Myelin content (Trmyelin) was strongly associated with axonal
count (r=−0.81, p<0.001) (Table 2, Fig. 4). Both Trmyelin and
axonal count were moderately associated with Trgliosis. More severe
gliosis correlated with lower myelin content and a smaller axonal
count (Table 3).
Table 2
Comparison (means, standard deviations, p values) of (i) white matter lesions (WMLs) versus normal-appearing white matter (NAWM), (ii) remyelinated WMLs
(rWMLs) versus NAWM and (iii) demyelinated WMLs (dWMLs) versus rWMLs in post mortem brain of patients with multiple sclerosis
WMLs (n=38) NAWM (n=16) p rWMLs (n=7) a NAWM (n=2) a p dWMLs (n=5) rWMLs b (n=3) p
MD 0.35 (0.09) 0.22 (0.04) <0.01 0.31 (0.07) 0.22 (0.03) 0.01 0.51 (0.12) 0.33 (0.10) 0.06
FA 0.22 (0.06) 0.38 (0.13) 0.01 0.23 (0.07) 0.38 (0.16) 0.01 0.19 (0.05) 0.24 (0.08) 0.17
Trmyelin 0.85 (0.09) 0.45 (0.10) <0.01 0.77 (0.07) 0.43 (0.12) <0.01 0.87 (0.04) 0.80 (0.06) <0.01
Axonal count 8.3 (5.1) 18.7 (2.0) <0.01 11.3 (4.8) 18.9 (2.5) 0.01 3.5 (1.7) 9.2 (0.4) 0.03
Trgliosis 0.76 (0.04) 0.80 (0.03) 0.08 0.75 (0.05) 0.80 (0.02) 0.05 0.76 (0.02) 0.79 (0.03) 0.59
MD=mean diffusivity [×10−3 mm2/s], FA=fractional anisotropy; Trmyelin= transmittance of slides stained for Luxol fast blue; Trgliosis= transmittance of slides
immuno-stained for glial fibrillary acidic protein.
a rWMLs were detected in two cases only.
b All fully remyelinated (i.e., shadow plaques).
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Predicting myelin content
The univariate correlation of Trmyelin with FA (−0.79, p<0.001)
is reduced to partial correlation −0.65, p<0.001 after adjustment
for MD. The univariate correlation between Trmyelin and MD
(r=0.68, p<0.001) is reduced to partial correlation 0.43, p=0.019
after adjusting for FA.
These results suggest that FA and MD are independently
associated with Trmyelin. The correlations remain robust when
adjusting for section thickness of the LFB-stained slides.
Predicting axonal count
The univariate correlation between axonal count and FA (0.70,
p=0.001) is substantially reduced and no longer significant when
adjusted for Trmyelin (partial r=0.16; p=0.399). Albeit reduced, the
association between axonal count and FA remains significant after
adjustment for Trgliosis (partial r=0.57, p=0.001).
The univariate correlation between axonal count and MD is
substantially reduced and no longer significant after adjustment for
Trmyelin (partial r=−0.24; p=0.212). The association between
axonal count and MD remains significant after adjustment for
Trgliosis (partial r=0.51, p=0.005).
Together, these results suggest that the correlations of axonal
count with both FA and MD are not independent of the (strong)
correlation between axonal count and Trmyelin, but unrelated to the
severity of gliosis. In a post hoc analysis box-plots were produced
to further illustrate the relationships between FA, myelin content
and axonal count (Fig. 5).Table 3
Correlations a between indices assessed in post mortem brain of patients with
multiple sclerosis
Pearson r * (n regions/n patients)
MD FA Trmyelin Axonal count
FA −0.62 (51/16)
Trmyelin 0.68 (45/15) −0.79 (45/15)
Axonal
count
−0.66 (44/15) 0.70 (44/15) −0.81 (44/15)
Trgliosis −0.55 (45/15) 0.50 (45/15) −0.51 (45/15) 0.62 (44/15)
MD=mean diffusivity; FA=fractional anisotropy; Trmyelin= transmittance of
slides stained for Luxol fast blue; Trgliosis= transmittance of slides immuno-
stained for glial fibrillary acidic protein.
a Within-patient Pearson correlation coefficients.
* p Value of all correlations was <0.01Predicting gliosis
We were unable to assess whether the univariate association
between Trgliosis and FA (r=0.50, p<0.01) is independent of
Trmyelin, as neither association is significant in a model with both.
Nor has it been possible to assess whether the association
between Trgliosis and MD (r=−0.55, p<0.01) is independent of
Trmyelin.
Comparison of demyelinated and remyelinated lesions
dWMLs had ∼60% lower axonal count (p=0.029) and a trend
for higher MD (p=0.061) and lower FA (p=0.167) than rWMLs
(Table 2).
Other histopathological lesions subgroups
No significant differences in MD or FA were seen between CA
and CI WMLs or between T1 hypo-intense and iso-intense
WMLs. There were too few EA WMLs to investigate this lesion
category.
None of the described relationships was substantially affected
by estimated EDSS, age, disease duration, time between death and
tissue retrieval, or time between death and MRI.
Batch and section thickness
The mean thickness of the histological sections was 9.4 μm
(SD: 3.6 μm), and 4.8 μm (SD: 0.7 μm) for LFB- and GFAP-
stained samples, respectively. Staining of the samples for LFB
and GFAP was performed in nine and six batches, respectively.
Trmyelin in WMLs did not vary with batch, but significant batch
variation was seen for Trmyelin in NAWM (p<0.001), and
borderline significance variation for Trgliosis in WMLs and
NAWM. None of the observed pathology–MR correlations were
affected by including section thickness and batch in the
regression analysis (correlation coefficients were altered by no
more than ±0.01, ±0.05 and significant p values by not more
than ±0.001, ±0.002 when adjusting for batch and thickness,
respectively).
Discussion
Pathological correlations of the MR measures
This study revealed strong univariate correlation of myelin
content as well as axonal content with MD and FA in chronic post
Fig. 4. Correlation between transmittance (Tr) of sections stained for Luxol
fast blue (Trmyelin, inversely proportional to myelin content) and axonal
count in post mortem multiple sclerosis brain (white matter lesions, normal-
appearing white matter).
Fig. 3. Correlation between diffusion indices and quantitative histology in post mortem multiple sclerosis brain (white matter lesions, normal-appearing white
matter). The plots illustrate the association of fractional anisotropy (FA) and mean diffusivity (MD) with (i) transmittance of sections stained for Luxol fast blue
(Trmyelin, inversely proportional to myelin content), (ii) transmittance of sections immuno-stained for glial fibrillary acidic protein (Trgliosis, inversely proportional
to severity of gliosis) and (iii) axonal count. See Table 3 for correlation coefficients.
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suggests that both indices MD and FA are primarily affected by
myelin content, whereas their correlation with axonal count is
largely explained by the strong association of the latter with
myelin content. This finding challenges the concept that an
increase in MD and decrease in FA of WMLs and/or NAWM
necessarily indicate the presence of axonal loss (Hesseltine et al.,
2006) in patients with progressive MS: on the contrary, the
findings suggest that loss of myelin per se is sufficient to produce
a significant change in both of these diffusion measures. Caution is
therefore recommended in using either MD or FA to make
inferences on axonal integrity per se.
Both, MD and FA as well as myelin content, axonal count and
the severity of gliosis were clearly different between WMLs and
NAWM. These differences were also robust in the subgroup of
rWMLs versus NAWM, though only marginal evidence emerged
for a difference of MD (and even less so for FA) between rWMLs
and dWMLs. This may be due to the limited sample size: whereas
in the analysis of rWMLs versus NAWM all rWMLs could be
included (of all cases in which rWMLs were detected areas of
NAWM were available for comparison), only cases with both
lesion types were included in the analysis of rWMLs versus
dWMLs. Compared to WMLs the standard deviation of FA was
larger in NAWM; FA in the former may have been consistently low
due to most WMLs exhibiting complete demyelination, whereas in
the NAWM, FA may vary considerably depending on the
orientation of fiber pathways and bundles in the ROI.The extent of fibrillary gliosis correlated moderately with
higher MD and lower FA. This correlation, however, was not
independent of the correlation of MD and FA with myelin content
(and axonal count). Hence, our data suggest that in chronic post
mortem MS brain MD and FA appear to be mainly affected by a
Fig. 5. Box-plots of fractional anisotropy (FA) in regions of interest (ROIs)
with (A) low myelin content (i.e., high transmittance of sections stained for
Luxol fast blue, Trmyelin) and (B) high axonal count. ROIs with low myelin
content and high axonal count are those below and above the respective
means over all ROIs. ROIs with low myelin content are shown divided into
those with low and high axonal counts: no difference in FA is evident
between these subgroups (p=0.49). ROIs with high axonal counts are shown
divided into those with high and low myelin content: ROIs with high myelin
content have a higher FA than ROIs with low myelin content (p<0.01).
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axonal loss – resulting in larger intercellular spaces (Barnes et al.,
1991; Larsson et al., 1992; Werring et al., 1999). Histologically, the
network of gliotic fibers appears to restrict the disorganization that
would result from demyelination and axonal damage alone, and it
has been suggested that this “repair” mechanism (fibrillary gliosis)
thereby limits the magnitude of MD and FA alterations in MS brain
(Rovaris et al., 2005). Our data suggest, however, that the potential
to quantify this effect using indices of MR diffusion may be
limited, at least in post mortem MS brain: in univariate correlation,
more severe gliosis was actually correlated with a higher MD,
although this apparent association is probably secondary to the
correlation between gliosis and demyelination.
No difference was detected in this study for any quantitative
index (MRI, histology) between CA and CI WMLs (Fig. 1)
suggesting that the extent of inflammation in chronic post mortem
MS brain tissue may have a minor effect on measures of MR
diffusion. However, the number of histopathologically active
WMLs in this sub-study was small, and the overall sample biasedtowards the late chronic stage of MS with limited inflammatory
activity of WMLs. In vivo studies in patients with MS suggested
that compared to chronic WMLs, MD is significantly higher and
FA lower in acute (Gd-enhancing) WMLs (Werring et al., 1999;
Roychowdhury et al., 2000), though published results have been
equivocal in this respect (Rovaris et al., 2005). More EA and CA
WMLs will have to be sampled to further elucidate the significance
of inflammation for MD and FA changes in MS brain.
With cautious reference to post mortem changes of diffusivity
in autopsy tissue (see below) our study suggests that in patients
with MS MD and FA both primarily reflect myelin content, while
axonal damage and (to a lesser degree) gliosis may also affect these
two measures of DTI. As our sample was limited to chronic post
mortem MS brain, no conclusions can be drawn about (i) the
possible effect of early inflammatory changes and (ii) changes in
the NAWM per se on MD and FA.
Methodological aspects of the study
Compared to published values acquired during an in vivo study
of MS patients using the same MR system (Werring et al., 1999),
the present post mortem study exhibits reduction in average MD in
NAWM of ∼75% (0.22 versus 0.88×10−3 mm2/s) and in WMLs
of ∼60% (0.35 versus 1.11×10−3 mm2/s); the reduction in average
FA is ∼one-third in NAWM (0.38 versus 0.56) and ∼56% in
WMLs (0.22 versus 0.50). These decreases likely reflect several
factors, including dehydration of post mortem tissue, the lower
temperature during post mortem MRI, and the breakdown of
energy-dependent ion transport mechanisms resulting in a net
influx of water into cells—thereby reducing the extra-cellular
space (Le et al., 1992; Lee et al., 1998; Gass et al., 2001). The
reduction in diffusivity of brain tissue following death is a well-
recognized phenomenon. In cats the diffusion coefficient compared
to pre mortem values dropped by up to 10% within 3 min and by
up to 50% within 15 min following death (Moseley et al., 1991). A
similar decrease of the diffusion coefficient post mortem has been
reported in rats (Wheeler-Kingshott et al., 2000). Due to ethical
and logistical issues involved in the handling of human post
mortem brain (Bö et al., 2004) it is difficult to systematically
establish, in human brain specimens, early post mortem changes
(i.e., within the first few hours after death) per se of MR diffusion.
In our sample, including time between death and MRI as a
covariate in the analysis revealed no systematic drift of the
acquired data. Nevertheless, the effects of temperature, post
mortem time and tissue decay need to be kept in mind when
trying to infer likely in vivo changes from data obtained from post
mortem tissue. It is noteworthy that in a study of mouse brain
diffusion anisotropy indices remained virtually unchanged when
images were acquired immediately after death (Sun et al., 2003),
and minimizing the post mortem time should provide a closer
approximation to the in vivo state. Nevertheless, the differences in
MD and FA that are seen between WMLs and NAWM in vivo
(higher MD and lower FA in WMLs) were clearly retained in this
post mortem study; the observations therefore allow inferences to
be drawn concerning the pathological substrates of diffusion
abnormalities in MS in vivo.
In order to take account of the reduced diffusivity in post
mortem brain samples and to improve the quality of DTI maps, the
MR acquisition had to be optimized differently from an in vivo
protocol. Susceptibility artefacts were reduced by introducing a
multi-shot (instead of a single-shot) EPI protocol, and a b factor of
475K. Schmierer et al. / NeuroImage 35 (2007) 467–4771940s/mm2 (i.e., almost twice as that used in optimized in vivo
protocols), was chosen to accommodate for the reduced diffusivity
in post mortem tissue. These measures allowed the acquisition of
images and maps (Fig. 2) of reasonable quality. An even greater b
factor of ∼4000s/mm2 would be desirable to further increase the
sensitivity to white matter changes at low FA values (Jones et al.,
1999).
Throughout this study we have focused on the investigation of
MS white matter. In our experience it is sometimes difficult to
unequivocally distinguish in post mortem brain between grey and
white matter, particularly when the distinction between the cortex
and white matter is concerned. This may, at least in part, be due to
volume averaging (Moore, 2003). The use of an inversion recovery
experiment may help to achieve better contrast between grey and
white matter in post mortem brain (Geurts et al., 2005). However,
this MR modality has not been applied in the current study.
Compared to scanning brain slices, MRI of the whole post
mortem brain (Newcombe et al., 1991) may have some advantages,
including better three-dimensional anatomic relationships and
landmarks, less dehydration and – if scanned in situ – fewer
susceptibility artefacts due to retained CSF (Bö et al., 2004).
Moreover, the brain in situ may decay more slowly due to the
“sterile” encapsulation of the brain in the skull, though microbial
contamination is only one among several factors (including post
mortem time, temperature and humidity) with influence on tissue
degradation. Apart from the limited availability of whole brains for
individual research projects, considerably more logistical efforts,
time and resources are required to set up a “whole-corpse” imaging
protocol (Bergers et al., 2002), and it may be difficult to achieve
optimum correspondence between the MR scans and their
pathological correlates (Bö et al., 2004), though results from
studies using marmosets are encouraging (Hart et al., 1998).
Future areas for MRI–pathology study in MS
Other quantitative MR measures that have been investigated
previously using post mortem MS brain include MT ratio (van
Waesberghe et al., 1999; Barkhof et al., 2003; Schmierer et al.,
2004a), T1 hypo-intensity (van Walderveen et al., 1998; Barkhof et
al., 2003; Schmierer et al., 2004a), T1-RT (Schmierer et al., 2004a)
and T2-RT (Moore et al., 2000). All have been associated with
myelin in MS brain with evidence for MT ratio being closely
related (Barkhof et al., 2003; Schmierer et al., 2004a). The
reliability of post mortem observations of MT ratio and T1-RT has
been enhanced by their apparent stability for up to 36 h post
mortem compared to published in vivo data (Schmierer et al.,
2004a). With FA and MD also appearing to reflect myelin content
and – to some degree – axonal loss, further research is needed to
seek more specific quantitative MR measures of both axonal loss
and myelin content per se. Since axonal loss is the likely
pathological substrate of irreversible and progressive disability in
MS – whereas demyelination alone has potential to allow
functional and structural recovery (through restoration of nerve
conduction and remyelination, respectively (Smith et al., 2006)) –
there is a pressing need for a more specific axonal marker.
Recent studies using animal models suggested that measures of
directional diffusivity other than FA may be able to distinguish
between axonal degeneration (increased axial diffusivity; normal
radial diffusivity) (Song et al., 2003) and loss of myelin per se, at
least in the early phase of myelin breakdown (increased radial
diffusivity; normal axial diffusivity) (Song et al., 2002). Thesestudies used longitudinally aligned structures such as the optic
nerve (Song et al., 2003), the corpus callosum (Song et al., 2005;
Sun et al., 2006) and the spinal cord (Kim et al., 2006). It may be
worthwhile to also investigate the radial and axial diffusivities of
these and similar structures in post mortem MS brain.
Further research should also investigate the pathological
correlates of MR tractography obtained from DTI data sets in post
mortem MS brain tissue. MR tractography is a relatively novel
application of DTI, which may have potential in quantifying the
degree of nerve fiber damage and loss in MS (Ge et al., 2005; Lin
et al., 2005) and other conditions such as amyotrophic lateral
sclerosis (Ciccarelli et al., 2006). Longitudinal brain structures
including the optic nerve, spinal cord or corpus callosum may be
most appropriate to investigate the quantitative pathological
correlates of MR tractography in MS brain.
Conclusion
In a post mortem study of subjects with progressive MS and
chronic WMLs, we have found a strong correlation of two standard
diffusion measures – MD and FA – with myelin content and – to a
lesser degree – axonal count. MD and FA appear in the present
study to be useful indicators of demyelination in MS. Further work
might usefully apply a similar multivariate analysis approach – as
in the present study – to investigate these and other potential MR
markers for their specificity in quantifying both myelin content and
axonal count.
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